Enovis Corporation (ENOV)

Compare

34.22

+3.56

+(11.61%)

At close: 4:00:02 PM EDT

34.00

-0.22

(-0.64%)

After hours: 5:05:01 PM EDT

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season.

StockStory 13 hours ago

ITGR

HAE

INSP
Enovis appoints Damien McDonald as CEO

McDonald, who is set to start as CEO on May 12, is joining a business that has expanded quickly in the orthopedic reconstruction sector.

MedTech Dive 2 days ago

ENOV
+11.61%
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENOV), a leader in medical technology innovation, today announced the appointment of Damien McDonald as Chief Executive Officer, effective May 12, 2025. Mr. McDonald will also join the Enovis Board of Directors following the conclusion of the Company’s 2025 Annual Mee

GlobeNewswire 7 days ago

ENOV
+11.61%
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 11.1%. This drop was worse than the S&P 500’s 4% loss.

StockStory 9 days ago

ENOV
+11.61%
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to exclusive events. Enovis Featured Products at ACFAS 2025 Enovis Foot & Ankle will be featuring these products at ACFAS 2025, March 27-30, in Phoenix, Arizona. WILMINGTON, DE, March 25, 2025 (GLOBE NEWSWIRE) -- Enovis™ (NYSE: ENOV), a global medical technology innovator, will feature its expanding portf

GlobeNewswire 15 days ago

ENOV
+11.61%
3 Stocks Under $50 in the Doghouse

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

StockStory 22 days ago

ENOV
+11.61%
WEN

LXFR
Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, March 05, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences: Canaccord Genuity Musculoskeletal Conference: Ben Berry, Chief Financial Officer, and Louie Vogt, Group President - Recon, will participate in a fireside chat on Monday, March 10th at 10:00 a.m. Pacific Time.37th Annual Roth Conference: Louie Vogt, Group Presid

GlobeNewswire last month

ENOV
+11.61%
Enovis Full Year 2024 Earnings: EPS Misses Expectations

Enovis ( NYSE:ENOV ) Full Year 2024 Results Key Financial Results Revenue: US$2.11b (up 24% from FY 2023). Net loss...

Simply Wall St. last month

ENOV
+11.61%
Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

Enovis Corp (ENOV) reports a robust 23% revenue increase and outlines strategic goals for 2025 amidst market challenges.

GuruFocus.com last month

ENOV
+11.61%
Q4 2024 Enovis Corp Earnings Call

Q4 2024 Enovis Corp Earnings Call

Thomson Reuters StreetEvents last month

ENOV
+11.61%
Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 6.52% and 0.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

ENOV
+11.61%
Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 23.3% year on year to $561 million. On the other hand, the company’s full-year revenue guidance of $2.21 billion at the midpoint came in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.98 per share was 7% above analysts’ consensus estimates.

StockStory last month

ENOV
+11.61%
Enovis: Q4 Earnings Snapshot

WILMINGTON, Del. AP) — Enovis Corporation (ENOV) on Wednesday reported a loss of $703.3 million in its fourth quarter. On a per-share basis, the Wilmington, Delaware-based company said it had a loss of $12.05.

Associated Press Finance last month

ENOV
+11.61%
Enovis Announces Fourth Quarter and Full Year 2024 Results

Continued commercial momentum with fourth-quarter sales growth of 23% on a reported basis and strong adjusted EBITDA margin expansion Fourth-quarter Reconstructive sales grew 59% year-over-year on a reported basis and 10% on a Comparable Sales basis Exceeded year one commercial and integration plans for Lima Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its fi

GlobeNewswire last month

ENOV
+11.61%
Enovis Announces Planned CEO Succession Process

Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has informed the Board of Directors (the “Board”) of his intention to retire from his position as Chief Executive Officer (CEO) of Enovis, effective upon his successor being appointed by the Board and assuming the position as CEO. As part of the Company’s succession planning process, the Board is actively wo

GlobeNewswire last month

ENOV
+11.61%
Enovis (ENOV) Q4 Earnings: What To Expect

Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect.

StockStory last month

ENOV
+11.61%
Talkspace, Inc. (TALK) Q4 Earnings Meet Estimates

Talkspace (TALK) delivered earnings and revenue surprises of 0% and 3.35%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

ENOV
+11.61%
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates

10x Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

TXG

ENOV
+11.61%
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2024 financial results on Wednesday, February 26th, 2025 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call as well as a webcast can be accessed from the "Investors" section

GlobeNewswire 2 months ago

ENOV
+11.61%
Zacks Industry Outlook Enovis, Omnicell and Phreesia

Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article.

Zacks 2 months ago

OMCL

ENOV
+11.61%
^GSPC

Performance Overview

Return	ENOV	S&P 500 (^GSPC)
YTD	-22.01%	-7.22%
1-Year	-45.19%	+4.74%
3-Year	-49.89%	+21.58%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Live

Enovis Corporation (ENOV)

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Enovis appoints Damien McDonald as CEO

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

3 Stocks Under $50 in the Doghouse

Enovis to Participate in Upcoming Investor Conferences

Enovis Full Year 2024 Earnings: EPS Misses Expectations

Enovis Corp (ENOV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

Q4 2024 Enovis Corp Earnings Call

Enovis (ENOV) Q4 Earnings and Revenues Surpass Estimates

Enovis (NYSE:ENOV) Exceeds Q4 Expectations

Enovis: Q4 Earnings Snapshot

Enovis Announces Fourth Quarter and Full Year 2024 Results

Enovis Announces Planned CEO Succession Process

Enovis (ENOV) Q4 Earnings: What To Expect

Talkspace, Inc. (TALK) Q4 Earnings Meet Estimates

10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Zacks Industry Outlook Enovis, Omnicell and Phreesia

Performance Overview